NVS - New safety risk for MorphoSys drug could complicate Novartis deal - STAT
2024-04-28 20:52:48 ET
More on MorphoSys
- MorphoSys AG (MOR) Q4 2023 Earnings Call Transcript
- Novartis And MorphoSys Are A Perfect Match
- Novartis commences tender offer for MorphoSys
- MorphoSys gains after gaining U.S. antitrust approval for sale to Novartis
- Seeking Alpha’s Quant Rating on MorphoSys